{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:58:16Z","timestamp":1769169496063,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ijrobp.2011.10.020","type":"journal-article","created":{"date-parts":[[2012,3,21]],"date-time":"2012-03-21T17:16:54Z","timestamp":1332350214000},"page":"1441-1447","source":"Crossref","is-referenced-by-count":39,"title":["A Phase I Clinical and Pharmacology Study Using Amifostine as a Radioprotector in Dose-escalated Whole Liver Radiation Therapy"],"prefix":"10.1016","volume":"83","author":[{"given":"Mary","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Normolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie C.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Ben-Josef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihua R.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Ensminger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.10.020_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0360-3016(01)01522-X","article-title":"Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model","volume":"50","author":"Symon","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib2","doi-asserted-by":"crossref","first-page":"8739","DOI":"10.1200\/JCO.2005.01.5354","article-title":"Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies","volume":"23","author":"Ben-Josef","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0360-3016(02)03929-9","article-title":"Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients","volume":"55","author":"Seong","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib4","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ijrobp.2006.06.015","article-title":"Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies\u2014mature results of the French Phase II RTF-1 trial","volume":"66","author":"Mornex","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2011.10.020_bib6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0959-8049(95)00145-9","article-title":"Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): Preclinical aspects","volume":"31A","author":"Peters","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib7","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(01)01713-8","article-title":"Randomized phase III trial of radiation treatment +\/- amifostine in patients with advanced-stage lung cancer","volume":"51","author":"Antonadou","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib9","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1200\/JCO.2005.04.3844","article-title":"Designing dose-escalation trials with late-onset toxicities using the time-to-event continual reassessment method","volume":"24","author":"Normolle","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib11","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/0360-3016(86)90203-8","article-title":"Human pharmacokinetics of WR-2721","volume":"12","author":"Shaw","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib13","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s002800050836","article-title":"Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography","volume":"42","author":"Souid","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1570-0232(02)00104-6","article-title":"New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065","volume":"772","author":"Bai","year":"2002","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib15","first-page":"313","article-title":"Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: Results of a phase I study","volume":"48","author":"Fiorentini","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib16","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ijrobp.2003.12.013","article-title":"Impact on cytoprotective efficacy of intermediate interval between amifostine administration and radiotherapy: A retrospective analysis","volume":"59","author":"Kouloulias","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/00912700222011201","article-title":"New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion","volume":"42","author":"Bonner","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib18","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0959-8049(97)00138-X","article-title":"Pharmacokinetics of amifostine and its metabolites in patients","volume":"33","author":"Korst","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2009.25.5638","article-title":"Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: Final results of the GORTEC2000-02 phase III randomized trial","volume":"29","author":"Bardet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.10.020_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00001622-200003000-00001","article-title":"Veno-occlusive disease of the liver","volume":"12","author":"Bearman","year":"2000","journal-title":"Curr Opin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611033827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611033827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T02:29:02Z","timestamp":1543112942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611033827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0360301611033827"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.020","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}